Roche obesity drug shows 15.5% weight loss in diabetes trial
Go back to Roche obesity drug shows 15.5% weight loss in diabetes trial| Amgen Inc (NASDAQ: AMGN) | Delayed: 414.61 +8.57 (2.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $406.04 | 52 Week High | $176.85 | |||
| Open | $408.25 | 52 Week Low | $133.64 | |||
| Day High | $415.20 | P/E | 62.44 | |||
| Day Low | $404.19 | EPS | $6.64 | |||
| Volume | 2,213,274 | |||||
| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 2,067,864 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1183.46 +1.57 (0.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1181.89 | 52 Week High | $88.16 | |||
| Open | $1185.32 | 52 Week Low | $67.88 | |||
| Day High | $1190.00 | P/E | 273.95 | |||
| Day Low | $1160.84 | EPS | $4.32 | |||
| Volume | 1,924,379 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 38.80 +0.18 (0.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $38.62 | 52 Week High | $59.00 | |||
| Open | $38.81 | 52 Week Low | $32.80 | |||
| Day High | $38.83 | P/E | N/A | |||
| Day Low | $38.41 | EPS | $0.00 | |||
| Volume | 10,177,259 | |||||
